Showing results (401-410 of 431) with videos related to

Sort By:
Pageof 44
Clinical Therapeutics|June 28, 2018
A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic RhinitisMi-Kyeong Kim, Sook Young Lee, Hae-Sim Park, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Allergy, Asthma & Immunology Research|June 24, 2024
Characteristics of Severe Asthma in the Elderly: Observations From the Korean Severe Asthma Registry (KoSAR)Hwa Young Lee, Da Woon Sim, Youngsoo Lee, et al.
Allergy|June 3, 2020
EAACI Biologicals Guidelines-Recommendations for severe asthmaIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Allergy, Asthma & Immunology Research|November 28, 2018
Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma RegistryMin Hye Kim, Sang Heon Kim, So Young Park, et al.
Allergy, Asthma & Immunology Research|April 21, 2018
Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire SurveySang Heon Kim, Ji Yong Moon, Jae Hyun Lee, et al.
Allergy|February 18, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Claudio Rocha, Jessica Beltran, et al.
The World Allergy Organization Journal|April 30, 2026
Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to actionMário Morais-Almeida, Giorgio Walter Canonica, Pedro Giavina-Bianchi, et al.
Pageof 44